Novo Nordisk is a global health care company with more than 88 years of unrivaled experience and leadership in the field of diabetic care. The company also holds leadership positions in the fields of hemophilia, growth hormone therapy, and hormone replacement therapy.

In 1923, the founder of the Danish company began a journey to change diabetes. Today, the company has thousands of employees around the world who are passionate, passionate, professional and committed to continuing the journey to prevention, treatment and ultimately help patients change their lives with the disease. diabetes mellitus.

Novo Nordisk plays a key role in developing new compounds that improve glycemic control; The company focuses on the factors involved in the formation or destruction of beta cells, the production of insulin, the regulation of appetite and the cumulative effects.

Headquartered in Denmark, Novo Nordisk now has approximately 31,400 employees in 74 countries, and promotes its products in more than 179 countries.

Novo Nordisk has been present in Vietnam since 1999. Novo Nordisk now plays a leading role in the insulin market in Vietnam and has a long-term partnership with DKSH in product distribution. Recently, Novo Nordisk has been granted a license to establish a representative office in Ho Chi Minh City, Vietnam. The opening of the representative office is a further step confirming Novo Nordisk's commitment to continue changing diabetes in Vietnam, working closely with health care workers to better improve their lives. diabetic patients.

AT & T is honored to be selected as a contractor for the supply of raised floors and vinyl tiles for the NOVO NORDISK office building in HCMC.